Breaking News

Lilly Opens Innovation Center in the Boston Seaport

Includes laboratories and office space and will also house the first Lilly Gateway Labs location on the East Coast.

Author Image

By: Charlie Sternberg

Associate Editor

Eli Lilly and Company has opened the Lilly Seaport Innovation Center (LSC), a research and development facility in the Boston Seaport dedicated to advancing Lilly’s efforts in RNA and DNA-based therapies as well as discovering new drug targets to create medicines across several disease states, including diabetes, obesity, cardiovascular diseases, neurodegeneration and chronic pain.   LSC occupies 346,000 square feet in a 12-story building, developed and operated by Alexandria Real Estate...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters